clinical disease
[용어속성] Disease
Early and High SARS-CoV-2 Neutralizing Antibodies Are Associated with Severity in COVID-19 Patients from India
초기 및 높은 SARS-CoV-2 중화 항체는 인도의 COVID-19 환자의 중증도와 관련이 있습니다
Article
[키워드] 1:1
association
Asymptomatic
asymptomatic individual
Asymptomatic individuals
asymptomatic infection
clinical disease
Clinical presentations
comparable
Contact
COVID-19
COVID-19 patient
defined
died
disease
disease severity
examined
exhibited
fatality
females
group
immune correlates
Immunopathogenesis
index cases
India
Live virus
male
males
Mild
mild illness
mild infections
NAb
NAb titer
NAb titers
NAbs
neutralization test
Neutralizing antibodies
neutralizing antibody
onset of disease
outcome
Patient
plaque reduction neutralization
Plaque reduction neutralization test
plasma
progression
proportion
SARS-CoV-2
SARS-COV-2 infection
screened
Seropositivity
serum
severe disease
severity
significantly higher
symptomatic infection
titers
were measured
[DOI] 10.4269/ajtmh.21-0014 PMC 바로가기 [Article Type] Article
[DOI] 10.4269/ajtmh.21-0014 PMC 바로가기 [Article Type] Article
SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution
Research
[키워드] ACE2
Administered
Affect
amino acid substitution
angiotensin-converting enzyme 2
antibodies
antiviral drug
applied
B.1.1.7
B1.351
Beta
binding
binding affinity
can be used
circulating
clinical disease
complex
Concentration
COVID-19 pandemic
Cryo-electron microscopy
E484K
Evolution
example
Gamma
GISAID database
higher affinity
in silico
in vitro
incidence
include
Infection
infection with SARS-CoV-2
inhibit
Multiple
mutagenic
mutant
Mutation
mutations
N501Y
P.1
positively correlated
provide
random
RBD
RBD binders
RBD mutation
receptor
reduced
resulting
S477N
SARS-CoV-2
SARS-CoV-2 variant
selected
significantly
the RBD
the receptor-binding domain
the spike protein
Vaccine development
variant
variants
virus
[DOI] 10.1038/s41564-021-00954-4 [Article Type] Research
[DOI] 10.1038/s41564-021-00954-4 [Article Type] Research
Clinical and Histopathologic Features of a Feline SARS-CoV-2 Infection Model Are Analogous to Acute COVID-19 in Humans
Article
[키워드] ACE2 expression
acute COVID-19
animal model
ARDS
clinical
clinical disease
controls
correlation
COVID-19
COVID-19 disease
Diffuse alveolar damage
distal
domestic cats
dry cough
Dyspnea
evaluate
feline
Fever
genetic modification
Hospitalized
Host
Human
humans
hyaline membrane formation
immune response
include
Infection
intratracheal
lesion
lesions
lethargy
Lungs
Model
nasal turbinates
other organs
pathology
produced
pulmonary
pulmonary lesions
quantified
Respiratory disease
Result
SARS-CoV-2
SARS-COV-2 infection
translational
urgency
viral infection
were infected
[DOI] 10.3390/v13081550 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/v13081550 PMC 바로가기 [Article Type] Article
Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2
Article
[키워드] Abstract
acute respiratory syndrome
administration
antibody
caused
clinical disease
Complete
coronavirus
coronavirus disease
COVID-19
COVID-19 pandemic
curtail
dose
effective
Efficacy
evaluated
expressing
hamster
hamsters
IgA
IgG2a
immunized
immunogenicity
immunoglobulin A
immunology
induce
Infection
Inflammation
intranasal
lesion
live-attenuated vaccine
lung
Lung infection
Lung inflammation
mice
nasal
nasal turbinate
Neutralizing
newcastle disease virus
pathology
Prevent
Protective
Protein
reduced
Safe
SARS-CoV-2
significantly
Spread
T-cell-mediated immunity
the SARS-CoV-2
undetectable
vaccination
Vaccine
Virology
virus transmission
[DOI] 10.1016/j.isci.2021.102941 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.isci.2021.102941 PMC 바로가기 [Article Type] Article
Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality
COVID-19 심각도 및 병원 내 사망률에 대한 예후 마커로서 아나필라톡신 및 염증성 사이토카인 보완
Immunology
[키워드] Activation
Analysis
anaphylatoxin
anaphylatoxins
C3a
C5a
changes in
chemokine
chemokines
clinical disease
clinical outcomes
complement
complement anaphylatoxins
Complement pathway
complement system
complications
COVID-19
COVID-19 patient
COVID-19 severity
Critical
critical COVID-19 patient
critical COVID-19 patients
critical patients
cytokine
Cytokine storm
Cytokines
deaths
dysregulation
enrolled
enzyme-linked immunosorbent
enzyme-linked immunosorbent assay
healthy control
healthy controls
highlight
Hospitalization
IgM antibody
IgM antibody levels
IL-1β
IL-6
IL-8
immunopathology
In-hospital
in-hospital mortality
infected with SARS-CoV-2
Inflammatory cytokine
Inflammatory cytokines
Inflammatory mediators
Innate immunity
Interaction
interleukin
investigated
mediators
mild cases
mild COVID-19 patients
mild patient
mild patients
Mortality
Necrosis
outcome
Patient
patients
patients with COVID-19
positively correlated
Potential treatment
Prognosis
prognostic
properdin
Protein
RANTES
SARS-COV-2 infection
SARS-CoV-2 infections
SARS‐CoV‐2
SARS‐CoV‐2
sera
serum
severe SARS
Signaling
significantly
significantly higher
survival group
target
Treatment strategies
treatment strategy
Tumor
tumor necrosis
tumor necrosis factor
upregulated
utility
were measured
[DOI] 10.3389/fimmu.2021.668725 PMC 바로가기 [Article Type] Immunology
[DOI] 10.3389/fimmu.2021.668725 PMC 바로가기 [Article Type] Immunology
Oral Microbiome Dysbiosis Is Associated With Symptoms Severity and Local Immune/Inflammatory Response in COVID-19 Patients: A Cross-Sectional Study
Microbiology
[키워드] analyzed
association
Bacteria
clinical disease
component
controls
coronavirus SARS-CoV-2
correlated
COVID-19
COVID-19 disease
COVID-19 patient
COVID-19 patients
determine
Dysbiosis
Evidence
fungi
GM-CSF
Gut
identify
IgA response
IL-17
immune response
Immunoglobulin
Inflammation
Inflammatory cytokines
Local
local immune response
local inflammation
marker
microbial community
Microbiome
mucosal
oral
Oral microbiome
other diseases
pandemic
parameter
PCR
primary site
pro-inflammatory cytokine
progression
Protective
quantified
Replication
respiratory virus
response
SARS-COV-2 infection
secretory IgA
shown
significantly
subjects
susceptibility
symptom severity
symptomatic patient
systemic diseases
the SARS-CoV-2
therapy
TNFα
to define
Vaccine development
virus
virus infection
virus replication
viruses
WGS
[DOI] 10.3389/fmicb.2021.687513 PMC 바로가기 [Article Type] Microbiology
[DOI] 10.3389/fmicb.2021.687513 PMC 바로가기 [Article Type] Microbiology
ABO phenotype and clinical correlates of COVID-19 severity in hospitalized patients
Research Article
[키워드] ABO
ABO blood type
Abstract
Admission
Analysis
Anemia
association
Blood
Blood Group
blood phenotype
clinical disease
confounding variables
COVID-19
COVID-19 disease
COVID-19 severity
death
diagnosed with COVID-19
Diagnosis
Diego
Disease progression
Evidence
Exploratory analyses
Exploratory analysis
FIVE
help
Hispanic
hospital
Hospitalization
Hospitalized
hospitalized patient
imperative
increased risk
intensive care
intubation
male
Male sex
Manifestations
material
morbidity and mortality
outcome
Patient
phenotype
predictor
San Diego
severity
Support
suppress
susceptibility
total patients
with COVID-19
[DOI] 10.2144/fsoa-2021-0045 PMC 바로가기 [Article Type] Research Article
[DOI] 10.2144/fsoa-2021-0045 PMC 바로가기 [Article Type] Research Article
A blood RNA transcriptome signature for COVID-19
Covid-19에 대한 혈액 RNA 전 사체 서명
Research
[키워드] abnormality
absence
age
All participants
Apoptosis
approach
Asymptomatic
Biomarkers
Blood
blood sample
chest X-ray
Chinese
clinical disease
clinical information
Confirmed COVID-19 infection
control group
correlated
Course
COVID-19
COVID-19 infection
COVID-19 patient
COVID-19 patients
Ct value
Ct values
dataset
datasets
determine
disease
disease manifestation
disease pathogenesis
disease severity
Ethnic groups
Ethnicity
evaluated
exposure to
expression
false-discovery rate
feature
Gender
Gene Expression
gene-expression
greater
healthy controls
healthy controls;
healthy volunteer
immunological
induced genes
Influenza
information
magnitude
median age
multiple organ involvement
nasal swab
onset of symptom
organ
other respiratory infection
other respiratory infections
parameters
participant
pathway
Pathways
Patient
presence or absence
Protein
qPCR
respiratory
respiratory infections
respiratory syncytial virus
respiratory viral infection
response
Result
RNA
RNA expression
RNA sequencing
RSV
SARS-CoV-2
similarity
South Asian
supplementary material
systemic disease
the disease
the patient
Transcriptome
unique
Viral
viral infection
viral infections
was collected
Whole blood
with COVID-19
[DOI] 10.1186/s12920-021-01006-w PMC 바로가기 [Article Type] Research
[DOI] 10.1186/s12920-021-01006-w PMC 바로가기 [Article Type] Research
Heterologous vaccine interventions: boosting immunity against future pandemics
Mini-Review
[키워드] Bacillus
BCG
boost
boosting immunity
caused
clinical disease
COVID-19 pandemic
disease
Effect
Effects
Heterologous
heterologous vaccine
Immunity
Infection
influenza vaccine
initial
Innate immunity
molecular mechanism
non-specific
non-specific immunity
Other
pandemic
Pandemics
pathogen
Pathogens
trained immunity
vaccination
Vaccine
while
widespread
[DOI] 10.1186/s10020-021-00317-z PMC 바로가기 [Article Type] Mini-Review
[DOI] 10.1186/s10020-021-00317-z PMC 바로가기 [Article Type] Mini-Review